← Leaderboards
James M Cook
University Of Wisconsin Milwaukee
$10,479,163
Attributed
$12,013,069
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$12,013,069 · 7
By mechanism
R01$10,933,873 · 5
P30$570,827 · 1
R43$508,369 · 1
Top collaborators
- David A Baker4 shared
- Rita A Fuchs Lokensgard2 shared
- Lalitha V Iyer2 shared
- Douglas C Lobner2 shared
- John R Mantsch2 shared
- Steven R Pollock2 shared
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsLeadBasePharmaceutical PreparationsPropertyAdverse EffectsReceptorDesignStructureFunctional DisorderEvaluationBenzodiazepinesIn VivoRattusAgonistMediatingBrainMissionQuality Of LifeMuscle RelaxantsAffectBenzodiazepine ReceptorAnticonvulsantsExhibits
Grant awards (35)
Development of new drugs for asthma by targeting GABA(A) receptors in the lung$478,857
R01 · FY2017 · HL · contact PI
Design of New Therapeutic Agents to Treat Schizophrenia$371,529
R01 · FY2017 · MH · contact PI
Development of new drugs for asthma by targeting GABA(A) receptors in the lung$478,857
R01 · FY2016 · HL · contact PI
Design of New Therapeutic Agents to Treat Schizophrenia$371,529
R01 · FY2016 · MH · contact PI
Development of new drugs for asthma by targeting GABA(A) receptors in the lung$471,673
R01 · FY2015 · HL · contact PI
Design of New Therapeutic Agents to Treat Schizophrenia$371,529
R01 · FY2015 · MH · contact PI
Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic Pain$318,422
R01 · FY2015 · NS · contact PI
Development of new drugs for asthma by targeting GABA(A) receptors in the lung$529,192
R01 · FY2014 · HL · contact PI
Design of New Therapeutic Agents to Treat Schizophrenia$371,529
R01 · FY2014 · MH · contact PI
Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic Pain$317,717
R01 · FY2014 · NS · contact PI
Design of New Therapeutic Agents to Treat Schizophrenia$383,904
R01 · FY2013 · MH · contact PI
Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic Pain$307,277
R01 · FY2013 · NS · contact PI
Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic Pain$318,422
R01 · FY2012 · NS · contact PI
Targeting System Xc- for the Treatment of Addiction$660,133
R01 · FY2010 · DA
Design and Synthesis of Anxioselective Anxiolytics$449,201
R01 · FY2010 · MH · contact PI
Targeting System Xc- for the Treatment of Addiction$773,859
R01 · FY2009 · DA
Design and Synthesis of Anxioselective Anxiolytics$442,211
R01 · FY2009 · MH · contact PI
Development of Compounds Targeting xc- for the Treatment of Schizophrenia$250,489
R43 · FY2009 · MH
FLOW CYTOMETRY FACILITY$158,434
P30 · FY2009 · CA · contact PI
Design and Synthesis of Anxioselective Anxiolytics$438,704
R01 · FY2008 · MH · contact PI
Development of Compounds Targeting xc- for the Treatment of Schizophrenia$257,880
R43 · FY2008 · MH
FLOW CYTOMETRY FACILITY$107,713
P30 · FY2008 · CA · contact PI
Design and Synthesis of Anxioselective Anxiolytics$438,422
R01 · FY2007 · MH · contact PI
FLOW CYTOMETRY FACILITY$104,576
P30 · FY2007 · CA · contact PI
Design and Synthesis of Anxioselective Anxiolytics$473,707
R01 · FY2006 · MH · contact PI
FLOW CYTOMETRY FACILITY$101,530
P30 · FY2006 · CA · contact PI
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$475,029
R01 · FY2005 · MH
FLOW CYTOMETRY FACILITY$98,574
P30 · FY2005 · CA
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$322,731
R01 · FY2004 · MH
Selective Anxiolytics via BzR Subtype Specific Ligands$101,500
R01 · FY2004 · MH
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$56,264
R01 · FY2004 · MH
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$322,952
R01 · FY2003 · MH
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$359,666
R01 · FY2002 · MH
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$359,871
R01 · FY2001 · MH
SELECTIVE ANXIOLYTICS VIA BZR SUBTYPE SPECIFIC LIGANDS$169,186
R01 · FY2000 · MH